New hope for men suffering from cancer treatment side effects
NCT ID NCT06972875
Summary
This study is testing a drug called fezolinetant to see if it can reduce hot flashes in men receiving hormone-blocking therapy for prostate cancer. Researchers want to find a non-hormonal way to manage this common and bothersome side effect that affects quality of life. The study involves 32 men who experience frequent hot flashes and will measure how well the drug reduces their frequency and severity over 4 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Vermont Medical Center
RECRUITINGBurlington, Vermont, 05401, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.